• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于冷冻球囊的心房颤动消融术前中性粒细胞/淋巴细胞比值与结局的关系。

Role of preablation neutrophil/lymphocyte ratio on outcomes of cryoballoon-based atrial fibrillation ablation.

机构信息

Department of Cardiology, Hacettepe University Faculty of Medicine, Ankara, Turkey.

出版信息

Am J Cardiol. 2013 Aug 15;112(4):513-9. doi: 10.1016/j.amjcard.2013.04.015. Epub 2013 May 11.

DOI:10.1016/j.amjcard.2013.04.015
PMID:23672989
Abstract

The neutrophil/lymphocyte ratio (NLR) has recently emerged as better indicator of inflammation and oxidative stress and has been widely studied in several cardiovascular diseases. In the present study, we evaluated the role of the preablation NLR in atrial fibrillation (AF) recurrence after cryoballoon-based catheter ablation. A total of 251 patients (47.8% women, age 54.12 ± 10.9 years, 80.1% with paroxysmal AF) with symptomatic AF underwent cryoablation. At a mean follow-up of 19.0 ± 6.6 months, 60 patients (23.9%) had developed AF recurrence. The patients who developed AF recurrence had had a greater preablation NLR (3.53 ± 0.95 vs 2.65 ± 0.23, p <0.001) and a higher white blood cell count, neutrophil count, and high-sensitivity C-reaction protein levels. On multivariate regression analysis, the preablation NLR (hazard ratio 2.15, 95% confidence interval 1.70 to 2.73, p <0.001), left atrial diameter (hazard ratio 1.09, 95% confidence interval 1.04 to 1.14, p <0.001) and early AF recurrence (hazard ratio 2.99, 95% confidence interval 1.71 to 5.23, p <0.001) were independent predictors of AF recurrence after cryoablation. Using a cutoff level of 3.15, the preablation NLR predicted AF recurrence during follow-up with a sensitivity of 84% and specificity of 75%. Patients with a preablation NLR >3.15 had a 2.5-fold increased risk of developing AF recurrence after cryoablation. In conclusion, an elevated preablation NLR was associated with increased AF recurrence after cryoballoon-based catheter ablation. Our results support the role of a preablation inflammatory environment in the development of AF recurrence after ablation therapy but suggest that other factors are also important.

摘要

中性粒细胞/淋巴细胞比值(NLR)最近被认为是炎症和氧化应激的更好指标,并在多种心血管疾病中得到了广泛研究。在本研究中,我们评估了消融前 NLR 在冷冻球囊导管消融后心房颤动(AF)复发中的作用。共有 251 名(47.8%为女性,年龄 54.12±10.9 岁,80.1%为阵发性 AF)有症状的 AF 患者接受了冷冻消融。平均随访 19.0±6.6 个月后,60 名(23.9%)患者发生了 AF 复发。发生 AF 复发的患者的消融前 NLR 更高(3.53±0.95 与 2.65±0.23,p<0.001),白细胞计数、中性粒细胞计数和高敏 C 反应蛋白水平更高。多变量回归分析显示,消融前 NLR(风险比 2.15,95%置信区间 1.70 至 2.73,p<0.001)、左心房直径(风险比 1.09,95%置信区间 1.04 至 1.14,p<0.001)和早期 AF 复发(风险比 2.99,95%置信区间 1.71 至 5.23,p<0.001)是冷冻消融后 AF 复发的独立预测因素。使用 3.15 的截断值,消融前 NLR 可预测随访期间 AF 复发的敏感性为 84%,特异性为 75%。消融前 NLR>3.15 的患者发生冷冻消融后 AF 复发的风险增加 2.5 倍。总之,升高的消融前 NLR 与冷冻球囊导管消融后 AF 复发增加相关。我们的结果支持消融前炎症环境在消融后 AF 复发中的作用,但表明其他因素也很重要。

相似文献

1
Role of preablation neutrophil/lymphocyte ratio on outcomes of cryoballoon-based atrial fibrillation ablation.基于冷冻球囊的心房颤动消融术前中性粒细胞/淋巴细胞比值与结局的关系。
Am J Cardiol. 2013 Aug 15;112(4):513-9. doi: 10.1016/j.amjcard.2013.04.015. Epub 2013 May 11.
2
The role of preprocedural monocyte-to-high-density lipoprotein ratio in prediction of atrial fibrillation recurrence after cryoballoon-based catheter ablation.术前单核细胞/高密度脂蛋白比值在预测冷冻球囊导管消融术后心房颤动复发中的作用。
Europace. 2015 Dec;17(12):1807-15. doi: 10.1093/europace/euu291. Epub 2015 May 19.
3
Predictors of atrial fibrillation recurrence after atrial fibrillation ablation with cryoballoon.冷冻球囊消融治疗心房颤动后心房颤动复发的预测因素。
Cardiol J. 2013;20(3):294-303. doi: 10.5603/CJ.2013.0075.
4
Usefulness of serum uric acid level to predict atrial fibrillation recurrence after cryoballoon-based catheter ablation.血清尿酸水平预测基于冷冻球囊导管消融术后房颤复发的效用。
Europace. 2014 Dec;16(12):1731-7. doi: 10.1093/europace/euu198. Epub 2014 Oct 29.
5
Postablation neutrophil/lymphocyte ratio correlates with arrhythmia recurrence after catheter ablation of lone atrial fibrillation.导管消融治疗孤立性心房颤动后,消融后中性粒细胞/淋巴细胞比值与心律失常复发相关。
Chin Med J (Engl). 2014;127(6):1033-8.
6
Incidence and significance of early recurrences of atrial fibrillation after cryoballoon ablation: insights from the multicenter Sustained Treatment of Paroxysmal Atrial Fibrillation (STOP AF) Trial.冷冻球囊消融术后心房颤动早期复发的发生率和意义:来自多中心阵发性心房颤动持续治疗(STOP AF)试验的结果。
Circ Arrhythm Electrophysiol. 2014 Feb;7(1):69-75. doi: 10.1161/CIRCEP.113.000586. Epub 2014 Jan 19.
7
Additional benefit of cryoballoon-based atrial fibrillation ablation beyond pulmonary vein isolation: modification of ganglionated plexi.基于冷冻球囊的房颤消融除肺静脉隔离以外的额外获益:神经节丛的修饰。
Europace. 2014 May;16(5):645-51. doi: 10.1093/europace/eut240. Epub 2013 Aug 16.
8
A proposal for a new scoring system in the prediction of catheter ablation outcomes: promising results from the Turkish Cryoablation Registry.一种新的评分系统在预测导管消融结果中的应用:来自土耳其冷冻消融登记处的有前途的结果。
Int J Cardiol. 2013 Nov 5;169(3):201-6. doi: 10.1016/j.ijcard.2013.08.097. Epub 2013 Sep 7.
9
Pre-ablative predictors of atrial fibrillation recurrence following pulmonary vein isolation: the potential role of inflammation.肺静脉隔离术后房颤复发的消融前预测因素:炎症的潜在作用。
Europace. 2009 Feb;11(2):158-63. doi: 10.1093/europace/eun309. Epub 2008 Nov 13.
10
Neutrophil to lymphocyte ratio is predictor of atrial fibrillation recurrence after cardioversion with amiodarone.中性粒细胞与淋巴细胞比值可预测胺碘酮转复心房颤动后复发。
Clin Appl Thromb Hemost. 2015 Jan;21(1):5-9. doi: 10.1177/1076029613518368. Epub 2014 Jan 14.

引用本文的文献

1
Inflammatory Markers and Postoperative New-Onset Atrial Fibrillation: Prognostic Predictions of Neutrophil Percent to Albumin Ratio in Patients with CABG.炎症标志物与术后新发房颤:冠状动脉旁路移植术患者中性粒细胞百分比与白蛋白比值的预后预测
Diagnostics (Basel). 2025 Mar 16;15(6):741. doi: 10.3390/diagnostics15060741.
2
Predictive value of neutrophil to lymphocyte ratio for clinical outcome in patients with atrial fibrillation: a systematic review and meta-analysis.中性粒细胞与淋巴细胞比值对心房颤动患者临床结局的预测价值:一项系统评价和荟萃分析
Front Cardiovasc Med. 2024 Sep 26;11:1461923. doi: 10.3389/fcvm.2024.1461923. eCollection 2024.
3
Factors predicting the recurrence of atrial fibrillation after catheter ablation: A review.
导管消融术后心房颤动复发的预测因素:综述
Heliyon. 2024 Jul 6;10(13):e34205. doi: 10.1016/j.heliyon.2024.e34205. eCollection 2024 Jul 15.
4
The association between systemic inflammation markers and paroxysmal atrial fibrillation.系统性炎症标志物与阵发性心房颤动的关系。
BMC Cardiovasc Disord. 2024 Jul 4;24(1):334. doi: 10.1186/s12872-024-04004-9.
5
Association between the neutrophil-to-lymphocyte ratio and in-hospital mortality in patients with chronic kidney disease and coronary artery disease in the intensive care unit.中性粒细胞与淋巴细胞比值与重症监护病房内慢性肾脏病合并冠状动脉疾病患者住院病死率的相关性。
Eur J Med Res. 2024 Apr 30;29(1):260. doi: 10.1186/s40001-024-01850-3.
6
Analyses of lncRNA and mRNA profiles in recurrent atrial fibrillation after catheter ablation.经导管消融后复发性心房颤动的 lncRNA 和 mRNA 谱分析。
Eur J Med Res. 2024 Apr 20;29(1):244. doi: 10.1186/s40001-024-01799-3.
7
Association between preablation and postablation neutrophil-lymphocyte ratio and atrial fibrillation recurrence: A meta-analysis.消融术前和术后中性粒细胞与淋巴细胞比值与心房颤动复发之间的关联:一项荟萃分析。
J Arrhythm. 2024 Jan 28;40(2):214-221. doi: 10.1002/joa3.12996. eCollection 2024 Apr.
8
Clinical and Laboratory Predictors of Long-Term Outcomes after Catheter Ablation for a Ventricular Electrical Storm.经导管消融治疗室性电风暴后长期预后的临床和实验室预测因素。
J Interv Cardiol. 2024 Feb 5;2024:5524668. doi: 10.1155/2024/5524668. eCollection 2024.
9
Effects of Inflammatory Cell Death Caused by Catheter Ablation on Atrial Fibrillation.导管消融引起的炎性细胞死亡对心房颤动的影响。
J Inflamm Res. 2023 Aug 17;16:3491-3508. doi: 10.2147/JIR.S422002. eCollection 2023.
10
Integrating the Left Atrium Diameter to Improve the Predictive Ability of the Age, Creatinine, and Ejection Fraction Score for Atrial Fibrillation Recurrence After Cryoballoon Ablation.将左心房直径纳入其中,可提高年龄、肌酐和射血分数评分对冷冻球囊消融后房颤复发的预测能力。
Anatol J Cardiol. 2023 Sep 30;27(10):567-572. doi: 10.14744/AnatolJCardiol.2023.2857. Epub 2023 Jun 15.